NVSEF
Price
$115.72
Change
+$1.29 (+1.13%)
Updated
Jun 3 closing price
Capitalization
216.52B
SNY
Price
$49.51
Change
+$0.32 (+0.65%)
Updated
Jun 4, 04:59 PM (EDT)
Capitalization
122.61B
57 days until earnings call
Interact to see
Advertisement

NVSEF vs SNY

Header iconNVSEF vs SNY Comparison
Open Charts NVSEF vs SNYBanner chart's image
Novartis AG
Price$115.72
Change+$1.29 (+1.13%)
Volume$1.23K
Capitalization216.52B
Sanofi ADS
Price$49.51
Change+$0.32 (+0.65%)
Volume$20.29K
Capitalization122.61B
NVSEF vs SNY Comparison Chart
Loading...
SNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NVSEF vs. SNY commentary
Jun 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NVSEF is a Hold and SNY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 05, 2025
Stock price -- (NVSEF: $115.72 vs. SNY: $49.19)
Brand notoriety: NVSEF and SNY are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: NVSEF: 4% vs. SNY: 129%
Market capitalization -- NVSEF: $216.52B vs. SNY: $122.61B
NVSEF [@Pharmaceuticals: Major] is valued at $216.52B. SNY’s [@Pharmaceuticals: Major] market capitalization is $122.61B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NVSEF’s FA Score shows that 3 FA rating(s) are green whileSNY’s FA Score has 1 green FA rating(s).

  • NVSEF’s FA Score: 3 green, 2 red.
  • SNY’s FA Score: 1 green, 4 red.
According to our system of comparison, NVSEF is a better buy in the long-term than SNY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SNY’s TA Score shows that 3 TA indicator(s) are bullish.

  • SNY’s TA Score: 3 bullish, 7 bearish.

Price Growth

NVSEF (@Pharmaceuticals: Major) experienced а +4.30% price change this week, while SNY (@Pharmaceuticals: Major) price change was -6.11% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +2.84%. For the same industry, the average monthly price growth was +2.05%, and the average quarterly price growth was +2.93%.

Reported Earning Dates

SNY is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+2.84% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NVSEF($217B) has a higher market cap than SNY($123B). NVSEF has higher P/E ratio than SNY: NVSEF (29.50) vs SNY (20.80). NVSEF YTD gains are higher at: 20.416 vs. SNY (6.510). NVSEF has higher annual earnings (EBITDA): 17.8B vs. SNY (12.6B). NVSEF has more cash in the bank: 11.2B vs. SNY (8.98B). SNY has less debt than NVSEF: SNY (18.4B) vs NVSEF (28.3B). NVSEF has higher revenues than SNY: NVSEF (53.1B) vs SNY (46.4B).
NVSEFSNYNVSEF / SNY
Capitalization217B123B176%
EBITDA17.8B12.6B141%
Gain YTD20.4166.510314%
P/E Ratio29.5020.80142%
Revenue53.1B46.4B114%
Total Cash11.2B8.98B125%
Total Debt28.3B18.4B154%
FUNDAMENTALS RATINGS
NVSEF vs SNY: Fundamental Ratings
NVSEF
SNY
OUTLOOK RATING
1..100
325
VALUATION
overvalued / fair valued / undervalued
1..100
15
Undervalued
7
Undervalued
PROFIT vs RISK RATING
1..100
3358
SMR RATING
1..100
2974
PRICE GROWTH RATING
1..100
4960
P/E GROWTH RATING
1..100
7585
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SNY's Valuation (7) in the Pharmaceuticals Major industry is in the same range as NVSEF (15) in the null industry. This means that SNY’s stock grew similarly to NVSEF’s over the last 12 months.

NVSEF's Profit vs Risk Rating (33) in the null industry is in the same range as SNY (58) in the Pharmaceuticals Major industry. This means that NVSEF’s stock grew similarly to SNY’s over the last 12 months.

NVSEF's SMR Rating (29) in the null industry is somewhat better than the same rating for SNY (74) in the Pharmaceuticals Major industry. This means that NVSEF’s stock grew somewhat faster than SNY’s over the last 12 months.

NVSEF's Price Growth Rating (49) in the null industry is in the same range as SNY (60) in the Pharmaceuticals Major industry. This means that NVSEF’s stock grew similarly to SNY’s over the last 12 months.

NVSEF's P/E Growth Rating (75) in the null industry is in the same range as SNY (85) in the Pharmaceuticals Major industry. This means that NVSEF’s stock grew similarly to SNY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SNY
RSI
ODDS (%)
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
51%
Momentum
ODDS (%)
Bearish Trend 2 days ago
51%
MACD
ODDS (%)
Bearish Trend 2 days ago
50%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
49%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
41%
Advances
ODDS (%)
Bullish Trend 15 days ago
53%
Declines
ODDS (%)
Bearish Trend 3 days ago
50%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
40%
Aroon
ODDS (%)
Bearish Trend 2 days ago
47%
View a ticker or compare two or three
Interact to see
Advertisement
SNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FNK50.530.87
+1.75%
First Trust Mid Cap Value AlphaDEX® ETF
REM21.130.35
+1.68%
iShares Mortgage Real Estate Capped ETF
ILDR27.210.27
+0.99%
First Trust Innovation Leaders ETF
AGRH25.860.11
+0.44%
iShares Interest Rt Hdg U.S. Aggt Bd ETF
TDTT24.02-0.04
-0.17%
FlexShares iBoxx 3Yr Target Dur TIPS ETF

NVSEF and

Correlation & Price change

A.I.dvisor tells us that NVSEF and SNYNF have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NVSEF and SNYNF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVSEF
1D Price
Change %
NVSEF100%
+1.13%
SNYNF - NVSEF
27%
Poorly correlated
+0.14%
SNY - NVSEF
21%
Poorly correlated
N/A
NVS - NVSEF
20%
Poorly correlated
-0.65%
KYKOF - NVSEF
7%
Poorly correlated
+4.43%
GIKLY - NVSEF
6%
Poorly correlated
N/A
More

SNY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNY has been loosely correlated with SNYNF. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if SNY jumps, then SNYNF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNY
1D Price
Change %
SNY100%
N/A
SNYNF - SNY
61%
Loosely correlated
+0.14%
GSK - SNY
47%
Loosely correlated
-2.88%
PFE - SNY
45%
Loosely correlated
-0.47%
NVS - SNY
45%
Loosely correlated
-0.65%
AZN - SNY
44%
Loosely correlated
-0.15%
More